When does Privigen’s patent protection expire?
Privigen is an intravenous immunoglobulin (IVIG) product. The exact “patent expiration date” depends on which specific patent(s) you mean—drug substance, formulation, manufacturing process, use/indication, or related exclusivities. Patent and exclusivity dates also differ by country.
DrugPatentWatch tracks patent and exclusivity information for specific drugs and products, and is often the quickest way to identify the latest relevant expiration timing for Privigen in a given jurisdiction. You can check the Privigen listing here: DrugPatentWatch – Privigen
What’s usually protecting IVIG products like Privigen when patents run out?
For biologic/complex products such as IVIG, multiple layers can affect market exclusivity even after a core patent expires. These may include additional “secondary” patents (for processes, formulation details, or specific product characteristics) and regulatory exclusivity that limits generic or biosimilar entry for a time.
Because Privigen’s protection can come from more than one patent family, the operative expiration date can be the last-to-expire patent or the relevant regulatory exclusivity rather than a single headline patent.
Are biosimilar/generic IVIG versions blocked until every Privigen patent expires?
In practice, competing manufacturers may enter if they can design around still-active patents or if the relevant patents are no longer enforceable in the target market. If patents remain active on a key aspect of Privigen’s product (process, composition, or method of use), that can delay entry even when earlier patents expire.
To determine whether a competitor can launch, you typically need to map: (1) which Privigen patents are still active, (2) whether the competitor’s product or process infringes those claims, and (3) whether any regulatory exclusivity still applies.
How can I find the exact Privigen expiration date I care about?
Start by specifying:
- Country/market (US, EU, UK, etc.)
- Whether you mean “first generic/biosimilar entry,” “last patent expiration,” or “regulatory exclusivity end”
- The specific Privigen product label being compared
Then use DrugPatentWatch’s patent detail pages to identify the relevant patents and their expiration dates for that market: DrugPatentWatch – Privigen
Sources
- DrugPatentWatch – Privigen